Literature DB >> 23151500

Raltegravir in the prevention of mother-to-child transmission of HIV-1: effective transplacental transfer and delayed plasma clearance observed in preterm neonates.

Aseel Hegazi, Denise Mc Keown, Katja Doerholt, Sheila Donaghy, Syed T Sadiq, Phillip Hay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23151500     DOI： 10.1097/QAD.0b013e32835a9aeb

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy.

Authors:  Bassam H Rimawi; Erica Johnson; Augustine Rajakumar; Sijia Tao; Yong Jiang; Scott Gillespie; Raymond F Schinazi; Mark Mirochnick; Martina L Badell; Rana Chakraborty
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

2.  Raltegravir pharmacokinetics in neonates following maternal dosing.

Authors:  Diana F Clarke; Edward P Acosta; Matthew L Rizk; Yvonne J Bryson; Stephen A Spector; Lynne M Mofenson; Edward Handelsman; Hedy Teppler; Carolee Welebob; Deborah Persaud; Mae P Cababasay; JiaJia Wang; Mark Mirochnick
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

3.  Short communication: Use of raltegravir in late-presenting HIV-infected pregnant women.

Authors:  Isabella Nóbrega; Ana Gabriela Travassos; Tatiana Haguihara; Fábio Amorim; Carlos Brites
Journal:  AIDS Res Hum Retroviruses       Date:  2013-06-25       Impact factor: 2.205

Review 4.  Use of Integrase Inhibitors in HIV-Infected Children and Adolescents.

Authors:  Walter Dehority; Jacobo Abadi; Andrew Wiznia; Rolando M Viani
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

5.  Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.

Authors:  Cécile Vinot; Jean-Marc Tréluyer; Carole Giraud; Laurent Gavard; Gilles Peytavin; Laurent Mandelbrot
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 6.  Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.

Authors:  Shelley A McCormack; Brookie M Best
Journal:  Clin Pharmacokinet       Date:  2014-11       Impact factor: 6.447

7.  Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1-Exposed Neonates at Risk of Infection (IMPAACT P1110).

Authors:  Diana F Clarke; Edward P Acosta; Mae Cababasay; Jiajia Wang; Anne Chain; Hedy Teppler; Stephanie Popson; Bobbie Graham; Betsy Smith; Rohan Hazra; Kat Calabrese; Yvonne Bryson; Stephen A Spector; Jos Lommerse; Mark Mirochnick
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.771

8.  Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission.

Authors:  Thanyawee Puthanakit; Nattawan Thepnarong; Surasith Chaithongwongwatthana; Suvaporn Anugulruengkitt; Orawan Anunsittichai; Tuangtip Theerawit; Sasiwimol Ubolyam; Chitsanu Pancharoen; Praphan Phanuphak
Journal:  J Virus Erad       Date:  2018-04-01

9.  A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes.

Authors:  I Boucoiran; K Tulloch; N Pick; F Kakkar; J van Schalkwyk; D Money; M Boucher
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 May-Jun       Impact factor: 2.471
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.